Bifidobacterium pseudocatenulatum
Bifidobacterium pseudocatenulatum is a beneficial probiotic strain that produces short-chain fatty acids (SCFAs) like butyrate to maintain gut barrier integrity. It colonizes the large intestine and modulates immune responses while competing with pathogenic bacteria for adhesion sites.
Origin & History
Bifidobacterium pseudocatenulatum is a gram-positive bacterium that is part of the natural gut microbiota in humans. It is known for its role in maintaining a healthy digestive system.
Historical & Cultural Context
Historically, this bacterium has been identified in traditional fermented foods, contributing to their probiotic properties. It is now commonly included in dietary supplements.
Health Benefits
- Enhances gut flora balance, improving digestion and reducing bloating for better overall gut health. This balance is crucial for nutrient absorption. - May reduce symptoms of irritable bowel syndrome (IBS) by decreasing gut inflammation, leading to less discomfort and improved quality of life. - Supports immune function by increasing the production of protective antibodies, helping the body fend off infections. - Promotes mental well-being by influencing the gut-brain axis, potentially reducing symptoms of anxiety and depression. - Aids in weight management by modulating gut hormones that control hunger, helping to reduce overeating. - Improves skin health by reducing systemic inflammation, leading to clearer, healthier skin. - Supports cardiovascular health by lowering cholesterol levels, as shown in studies where it reduced LDL cholesterol by up to 10%.
How It Works
Bifidobacterium pseudocatenulatum ferments dietary fiber to produce short-chain fatty acids, particularly butyrate, which strengthens intestinal tight junctions and reduces gut permeability. It stimulates regulatory T-cell production through interactions with toll-like receptor 2 (TLR2) and modulates cytokine release, decreasing pro-inflammatory IL-6 and TNF-α levels. The strain also produces bacteriocins and competitive exclusion mechanisms that inhibit pathogenic bacterial adherence to intestinal epithelial cells.
Scientific Research
Research indicates Bifidobacterium pseudocatenulatum may improve gut health and modulate immune responses, although further studies are needed for conclusive evidence.
Clinical Summary
Limited human clinical trials have evaluated Bifidobacterium pseudocatenulatum specifically, with most evidence coming from in vitro and animal studies. One small randomized controlled trial (n=45) showed 30% reduction in IBS symptom severity scores after 8 weeks of supplementation with multi-strain formulas containing this organism. Preclinical studies demonstrate significant anti-inflammatory effects and improved gut barrier function, but larger human trials are needed to confirm therapeutic efficacy. Current evidence suggests beneficial effects but requires more robust clinical validation.
Nutritional Profile
- Contains beneficial live bacteria. - Produces lactic acid and short-chain fatty acids. - Contributes to the digestion of complex carbohydrates.
Preparation & Dosage
Typically consumed in doses of 1-10 billion CFUs per day. Consult a healthcare provider before use.
Synergy & Pairings
Prebiotics, Lactobacillus rhamnosus, Bifidobacterium breve
Safety & Interactions
Bifidobacterium pseudocatenulatum is generally recognized as safe (GRAS) with minimal reported adverse effects in healthy individuals. Mild gastrointestinal symptoms like temporary bloating or gas may occur during initial supplementation as gut microbiota adjusts. Immunocompromised patients should consult healthcare providers before use due to rare cases of probiotic bacteremia reported with Bifidobacterium species. No significant drug interactions are documented, though it may theoretically affect antibiotic efficacy if taken concurrently.